TAKEDA PHARMACEUTICAL CO LTD
CIK 1395064 · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$53.54M
Companies
8
Total Filings
31
Lifetime Open-Market Net
-$96.92M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OVID | 10%+ Owner | 8,781,996 | $2.22 | $19.50M | $0 | 2 | 2025-12-09 |
| PHAT | 10%+ Owner | 3,755,583 | $8.81 | $33.08M | -$58.48M | 22 | 2024-01-25 |
| HilleVax, Inc. (HLVX) Delisted | 10%+ Owner | 6,724,000 | $2.09 | $14.05M | $0 | 1 | 2022-12-01 |
| Calithera Biosciences, Inc. (CALA) Delisted | 10%+ Owner | — | $0.00 | — | $0 | 1 | 2022-07-06 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | 10%+ Owner | 6,230,462 | $21.53 | $134.14M | -$29.97M | 2 | 2021-12-09 |
| XLO | 10%+ Owner | 105,366 | $9.07 | $955.7K | $0 | 1 | 2021-10-26 |
| Theseus Pharmaceuticals, Inc. (THRX) Delisted | 10%+ Owner | 1,615,427 | $4.06 | $6.56M | $0 | 1 | 2021-10-15 |
| Translate Bio, Inc. (TBIO) Delisted | 10%+ Owner | 387,248 | $0.00 | $39 | -$8.47M | 1 | 2020-06-03 |
Recent Filings · Page 3 of 4
31 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-06-04 | PHAT | Sell (S) | −4,300 | -$151.3K | EDGAR |
| 2021-06-02 | PHAT | Sell (S) | −20,116 | -$723.4K | EDGAR |
| 2021-05-28 | PHAT | Sell (S) | −20,811 | -$766.7K | EDGAR |
| 2021-05-26 | PHAT | Sell (S) | −21,541 | -$773.9K | EDGAR |
| 2021-05-24 | PHAT | Sell (S) | −18,746 | -$665.4K | EDGAR |
| 2021-05-18 | PHAT | Sell (S) | −100 | -$3.5K | EDGAR |
| 2021-05-14 | PHAT | Sell (S) | −11,876 | -$420.9K | EDGAR |
| 2021-05-11 | PHAT | Sell (S) | −1,011 | -$35.4K | EDGAR |
| 2021-05-07 | PHAT | Sell (S) | −7,138 | -$250.8K | EDGAR |
| 2021-05-05 | PHAT | Sell (S) | −33,992 | -$1.26M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.